SIFASI HP 2000 I.U

Product Overview – SIFASI HP 2000 I.U.

SIFASI HP 2000 I.U. is an advanced formulation serum iron supplement with iron bis-glycinate chelate (IBGC) and heptahydrate ferric ammonium citrate (HFC). It is uniquely designed to help in iron deficiency and anemia. SIFASI HP 2000 I.U. has higher bioavailability enabling faster absorption and is gentle on the gastrointestinal system. This formulation helps in faster recovery and sustained iron levels in the body.

Pharmacological Properties

SIFASI HP 2000 I.U. is available in the form of a sterile sodium chloride solution for intravenous and intramuscular injection. The active ingredients in SIFASI HP 2000 are Iron Bis-Glycinate Chelate (IBGC) and Heptahydrate Ferric Ammonium Citrate (HFC). Both ingredients have different pharmacological properties. Iron Bis-Glycinate Chelate (IBGC) is a highly bioavailable form of iron, which is more efficiently absorbed than other forms of iron. It helps in improving hematopoiesis and is beneficial in the treatment of iron deficiency anaemia. The Heptahydrate Ferric Ammonium Citrate (HFC) formulation helps in supplying iron and other essential nutrients to the body quickly and safely.

Effects and Side Effects

SIFASI HP 2000 I.U. is an advanced serum iron supplement formulation and is highly effective in treating iron deficiency and anemia. It produces a sustained response over an extended period of time and is gentle on the gastrointestinal system. Regular use helps in correcting anemia as well as improving overall health. Few common side effects include upset stomach, vomiting, diarrhea, constipation, and headache.

Correct Dosage and Overdose

The recommended dosage of SIFASI HP 2000 I.U. is 1-2 ampoules per week administered intravenously or intramuscularly. It is recommended to start with low doses and gradually increase the dose based on the individual’s needs and response. An overdose may lead to increase in serum iron levels, resulting in abdominal pain, nausea, vomiting, and fatigue. In case of overdose, medical attention is advised.

Indications and Contraindications

SIFASI HP 2000 I.U. is indicated in iron deficiency and anemia due to postpartum, malabsorption, iron deficiency, pregnancy, and other causes. It is also indicated in acute blood loss situations and hemolysis. The product is contraindicated in patients with known hypersensitivity to iron salts, renal impairment, and in those with hemochromatosis.

Value to the Customer

SIFASI HP 2000 I.U. is an advanced serum iron supplement specifically formulated to provide maximum efficiency and safety while addressing iron deficiency and anemia. It is easy to administer and provides faster recovery and sustained iron levels in the body. Its high bioavailability formulation enables faster absorption in the body and is gentle on the gastrointestinal system. It helps in restoring normal iron levels in the body providing the customer with better overall health.